News & Media

All Resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Media Coverage
Media Coverage
May 1, 2023
2023
2023

BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13

Learn More
Media Coverage
May 1, 2023
2023
2023

BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13

Learn More
Press Releases
Press Releases
January 23, 2023
2023
2023

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

Learn More
Press Releases
January 23, 2023
2023
2023

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

Learn More
Press Releases
Press Releases
December 16, 2022
2022
2022

BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company's Rapid Growth

Learn More
Press Releases
December 16, 2022
2022
2022

BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company's Rapid Growth

Learn More
Press Releases
Press Releases
December 6, 2022
2022
2022

BillionToOne Announces New Clinical Outcomes Data Showing High Sensitivity of UNITY Screen™ to Detect Pregnancies at Risk for Recessive Conditions

Learn More
Press Releases
December 6, 2022
2022
2022

BillionToOne Announces New Clinical Outcomes Data Showing High Sensitivity of UNITY Screen™ to Detect Pregnancies at Risk for Recessive Conditions

Learn More
Press Releases
Press Releases
December 2, 2022
2022
2022

BillionToOne Appoints Tom Lynch, JD, as General Counsel & Chief Compliance Officer

Learn More
Press Releases
December 2, 2022
2022
2022

BillionToOne Appoints Tom Lynch, JD, as General Counsel & Chief Compliance Officer

Learn More
General Information
General Information
October 31, 2022
2022
2022

CA Superior Court Halts CDPH’s Exclusivity of Trisomy Screening Through the CA PNS Program

Learn More
General Information
October 31, 2022
2022
2022

CA Superior Court Halts CDPH’s Exclusivity of Trisomy Screening Through the CA PNS Program

Learn More
Press Releases
Press Releases
September 30, 2022
2022
2022

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

Learn More
Press Releases
September 30, 2022
2022
2022

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

Learn More
Media Coverage
Media Coverage
August 4, 2022
2022
2022

BillionToOne Ranked a Top Healthcare Technology Company of 2022

Learn More
Media Coverage
August 4, 2022
2022
2022

BillionToOne Ranked a Top Healthcare Technology Company of 2022

Learn More